Literature DB >> 22669402

Rationale and design of an International Multicenter Registry of patients with repaired tetralogy of Fallot to define risk factors for late adverse outcomes: the INDICATOR cohort.

Anne Marie Valente1, Kimberlee Gauvreau, Gabriele Egidy Assenza, Sonya V Babu-Narayan, Sarah P Evans, Michael Gatzoulis, Maarten Groenink, Ryo Inuzuka, Philip J Kilner, Zeliha Koyak, Michael J Landzberg, Barbara Mulder, Andrew J Powell, Rachel Wald, Tal Geva.   

Abstract

Although early survival after tetralogy of Fallot (TOF) repair in the modern era is excellent, studies on late outcomes have shown increasing rates of mortality and morbidity. Despite multiple publications on factors associated with late complications, risk factors for major outcomes (death and sustained ventricular tachycardia [VT]) remain poorly defined. Consequently, the International Multicenter TOF Registry (INDICATOR) was established. This article describes the development, structure, and goals of this registry and characterizes the initial cohort derived from four large congenital heart centers in the United States, Canada, and Europe. A data coordinating center with a core cardiac magnetic resonance (CMR) laboratory and statistical core was established. Subjects with repaired TOF who had CMR imaging performed between 1997 and 2010 and ≥ 1 year follow-up were included. Clinical end points were death and sustained VT. Demographic, electrophysiologic, exercise, and outcome data were collected. A total of 873 subjects fulfilled inclusion criteria (median age at repair 2.9 years and at CMR imaging 22.8 years). Of these, 9 % had QRS duration >180 ms on electrocardiogram (ECG). On CMR imaging, 38 % had severe right-ventricular (RV) dilatation (≥ 160 mL/m(2)), and 6 % had severe RV dysfunction (ejection fraction < 35 %). Of the 551 subjects with exercise testing available, 28 % had severely decreased exercise capacity with <50 % predicted peak oxygen consumption. The INDICATOR cohort allows robust statistical analysis to evaluate major clinical outcomes in patients with repaired TOF. Continued follow-up and further expansion of the registry may provide new insights into innovative therapeutic strategies to improve late outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22669402     DOI: 10.1007/s00246-012-0394-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  21 in total

1.  Effects of metallic implants on magnetic resonance imaging evaluation of Fontan palliation.

Authors:  Ruchira Garg; Andrew J Powell; Laureen Sena; Audrey C Marshall; Tal Geva
Journal:  Am J Cardiol       Date:  2005-03-01       Impact factor: 2.778

2.  Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome.

Authors:  Sonya V Babu-Narayan; Philip J Kilner; Wei Li; James C Moon; Omer Goktekin; Periklis A Davlouros; Mohammed Khan; Siew Yen Ho; Dudley J Pennell; Michael A Gatzoulis
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

3.  Long-term results after early primary repair of tetralogy of Fallot.

Authors:  E A Bacha; A M Scheule; D Zurakowski; L C Erickson; J Hung; P Lang; J E Mayer; P J del Nido; R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2001-07       Impact factor: 5.209

4.  Relation of right ventricular dilation, age of repair, and restrictive right ventricular physiology with patient-reported quality of life in adolescents and adults with repaired tetralogy of fallot.

Authors:  Jimmy C Lu; Timothy B Cotts; Prachi P Agarwal; Anil K Attili; Adam L Dorfman
Journal:  Am J Cardiol       Date:  2010-11-02       Impact factor: 2.778

5.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.

Authors:  M A Gatzoulis; S Balaji; S A Webber; S C Siu; J S Hokanson; C Poile; M Rosenthal; M Nakazawa; J H Moller; P C Gillette; G D Webb; A N Redington
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

6.  Range of ventricular dimensions and function by steady-state free precession cine MRI in repaired tetralogy of Fallot: right ventricular outflow tract patch vs. conduit repair.

Authors:  Margaret M Samyn; Andrew J Powell; Ruchira Garg; Laureen Sena; Tal Geva
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

7.  Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study.

Authors:  Paul Khairy; Michael J Landzberg; Michael A Gatzoulis; Hugues Lucron; Jean Lambert; François Marçon; Mark E Alexander; Edward P Walsh
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

8.  Implantable cardioverter-defibrillators in tetralogy of Fallot.

Authors:  Paul Khairy; Louise Harris; Michael J Landzberg; Sangeetha Viswanathan; Amanda Barlow; Michael A Gatzoulis; Susan M Fernandes; Luc Beauchesne; Judith Therrien; Philippe Chetaille; Elaine Gordon; Isabelle Vonder Muhll; Frank Cecchin
Journal:  Circulation       Date:  2008-01-02       Impact factor: 29.690

9.  Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot.

Authors:  Rachel M Wald; Idith Haber; Ron Wald; Anne Marie Valente; Andrew J Powell; Tal Geva
Journal:  Circulation       Date:  2009-03-02       Impact factor: 29.690

10.  Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology.

Authors:  Philip J Kilner; Tal Geva; Harald Kaemmerer; Pedro T Trindade; Juerg Schwitter; Gary D Webb
Journal:  Eur Heart J       Date:  2010-01-11       Impact factor: 29.983

View more
  8 in total

Review 1.  The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot.

Authors:  Frederic Dallaire; Rachel M Wald; Ariane Marelli
Journal:  Pediatr Cardiol       Date:  2017-06-16       Impact factor: 1.655

2.  TBX1 loss-of-function mutation contributes to congenital conotruncal defects.

Authors:  Min Zhang; Fu-Xing Li; Xing-Yuan Liu; Jing-Yi Hou; Shi-Hong Ni; Juan Wang; Cui-Mei Zhao; Wei Zhang; Ye Kong; Ri-Tai Huang; Song Xue; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

3.  A novel NKX2.6 mutation associated with congenital ventricular septal defect.

Authors:  Juan Wang; Jian-Hui Mao; Ke-Ke Ding; Wei-Jun Xu; Xing-Yuan Liu; Xing-Biao Qiu; Ruo-Gu Li; Xin-Kai Qu; Ying-Jia Xu; Ri-Tai Huang; Song Xue; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2014-11-08       Impact factor: 1.655

4.  A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Authors:  Yun Pan; Zha-Gen Wang; Xing-Yuan Liu; Hong Zhao; Ning Zhou; Gui-Fen Zheng; Xing-Biao Qiu; Ruo-Gu Li; Fang Yuan; Hong-Yu Shi; Xu-Min Hou; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2015-04-10       Impact factor: 1.655

5.  Detection of persistent systolic and diastolic abnormalities in asymptomatic pediatric repaired tetralogy of Fallot patients with preserved ejection fraction: a CMR feature tracking study.

Authors:  Rongzhen Ouyang; Shuang Leng; Aimin Sun; Qian Wang; Liwei Hu; Xiaodan Zhao; Qin Yan; Ru-San Tan; Liang Zhong; Yumin Zhong
Journal:  Eur Radiol       Date:  2021-01-25       Impact factor: 5.315

6.  Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.

Authors:  Anne Marie Valente; Kimberlee Gauvreau; Gabriele Egidy Assenza; Sonya V Babu-Narayan; Jenna Schreier; Michael A Gatzoulis; Maarten Groenink; Ryo Inuzuka; Philip J Kilner; Zeliha Koyak; Michael J Landzberg; Barbara Mulder; Andrew J Powell; Rachel Wald; Tal Geva
Journal:  Heart       Date:  2013-10-31       Impact factor: 5.994

7.  Right-left ventricular shape variations in tetralogy of Fallot: associations with pulmonary regurgitation.

Authors:  Charlène A Mauger; Sachin Govil; Radomir Chabiniok; Kathleen Gilbert; Sanjeet Hegde; Tarique Hussain; Andrew D McCulloch; Christopher J Occleshaw; Jeffrey Omens; James C Perry; Kuberan Pushparajah; Avan Suinesiaputra; Liang Zhong; Alistair A Young
Journal:  J Cardiovasc Magn Reson       Date:  2021-10-07       Impact factor: 5.364

8.  Risk Factors of Right Ventricular Dysfunction and Adverse Cardiac Events in Patients with Repaired Tetralogy of Fallot.

Authors:  Benedetta Leonardi; Camilla Calvieri; Marco Alfonso Perrone; Arianna Di Rocco; Adriano Carotti; Massimo Caputo; Aurelio Secinaro; Davide Curione; Maria Giulia Gagliardi; Paolo Guccione; Sonia Albanese; Lorenzo Galletti; Fabrizio Drago
Journal:  Int J Environ Res Public Health       Date:  2021-10-08       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.